NARI - Inari Medical Stock

Market Summary

USD65.80-0.41

Market Closed

-0.62%

NARI Alerts

2 major insider sales recently.
Big jump in Revenue (Y/Y)
Big jump in Earnings (Y/Y)

NARI Stock Price

NARI RSI Chart

NARI Valuation

Market Cap

3.8B

Price/Earnings (Trailing)

-235.74

Price/Sales (Trailing)

8.63

EV/EBITDA

-541.75

Price/Free Cashflow

-11.0K

NARI Price/Sales (Trailing)

NARI Profitability

EBT Margin

-5.87%

Return on Equity

-6.64%

Return on Assets

-5.6%

Free Cashflow Yield

-0.01%

NARI Fundamentals

NARI Revenue

Revenue (TTM)

439.1M

Revenue Y/Y

28.32%

Revenue Q/Q

2.44%

NARI Earnings

Earnings (TTM)

-16.1M

Earnings Y/Y

120.47%

Earnings Q/Q

194%

Price Action

52 Week Range

52.5983.84

(Low)(High)

Last 7 days

2.4%

Last 30 days

-0.2%

Last 90 days

16.8%

Trailing 12 Months

-8.8%

NARI Financial Health

Current Ratio

8.8

NARI Investor Care

Shares Dilution (1Y)

7.68%

Diluted EPS (TTM)

-0.29

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for NARI

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-09-15	Hoffman William	sold	-1,668,500	66.7401	-25,000	-
2023-09-12	Hill, Mitch C.	sold	-441,040	67.8523	-6,500	chief financial officer
2023-09-12	Hill, Mitch C.	acquired	2,970	0.457	6,500	chief financial officer
2023-08-16	Tu Thomas	sold	-1,647,980	66.1149	-24,926	chief medical officer
2023-08-16	Hykes Andrew	sold	-2,424,830	66.1149	-36,676	president and ceo
2023-08-15	Hoffman William	sold	-1,725,540	69.0215	-25,000	-
2023-08-14	Hill, Mitch C.	acquired	2,970	0.457	6,500	chief financial officer
2023-08-14	Hill, Mitch C.	sold	-458,053	70.4697	-6,500	chief financial officer
2023-07-17	Hoffman William	sold	-1,426,910	57.0765	-25,000	-
2023-07-12	Hill, Mitch C.	acquired	2,970	0.457	6,500	chief financial officer

Which funds bought or sold NARI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-09-26	BROOKFIELD Corp /ON/	sold off	-100	-1,437,060	-	-%
2023-09-20	BARCLAYS PLC	added	159	8,259,000	13,996,000	0.01%
2023-08-22	COMERICA BANK	new	-	52,000	52,000	-%
2023-08-22	VIRGINIA RETIREMENT SYSTEMS ET AL	new	-	360,468	360,468	-%
2023-08-21	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	added	5.65	-17,577	3,418,750	-%
2023-08-21	Affinity Asset Advisors, LLC	sold off	-100	-1,234,800	-	-%
2023-08-21	OSAIC HOLDINGS, INC.	added	36.11	38,002	172,877	-%
2023-08-21	TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY	added	20.05	665,000	5,766,000	0.06%
2023-08-18	Legato Capital Management LLC	new	-	994,834	994,834	0.14%
2023-08-17	Orion Portfolio Solutions, LLC	reduced	-5.02	-78,179	662,331	0.01%

Latest Funds Activity

Are funds buying NARI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NARI

No. of Funds

Schedule 13G FIlings of Inari Medical

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 24, 2023	point72 asset management, l.p.	4.9%	2,611,241	SC 13G
Feb 14, 2023	macquarie group ltd	3.38%	1,814,852	SC 13G/A
Feb 14, 2023	alliancebernstein l.p.	4.1%	2,183,673	SC 13G/A
Feb 13, 2023	capital international investors	0.1%	72,099	SC 13G/A
Feb 13, 2023	milder donald b	6.0%	3,225,220	SC 13G/A
Feb 10, 2023	cvf, llc	4.8%	2,591,665	SC 13G/A
Feb 09, 2023	vanguard group inc	8.07%	4,331,429	SC 13G/A
Feb 06, 2023	wellington management group llp	9.20%	4,938,574	SC 13G/A
Jan 26, 2023	blackrock inc.	10.6%	5,671,100	SC 13G/A
Jan 20, 2023	blackrock inc.	10.6%	5,671,100	SC 13G/A

Recent SEC filings of Inari Medical

View All Filings

Date Filed	Form Type	Document
Sep 22, 2023	8-K	Current Report
Sep 19, 2023	4	Insider Trading
Sep 15, 2023	144	Notice of Insider Sale Intent
Sep 14, 2023	4	Insider Trading
Aug 18, 2023	4	Insider Trading
Aug 18, 2023	4	Insider Trading
Aug 17, 2023	4	Insider Trading
Aug 16, 2023	144/A	144/A
Aug 16, 2023	4	Insider Trading
Aug 15, 2023	144	Notice of Insider Sale Intent

Peers (Alternatives to Inari Medical)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
AAPL	2.7T	383.9B	-8.29%	25.93%	28.47	7.03	-0.93%	-4.89%
MSFT	2.3T	211.9B	-2.09%	38.56%	32.19	10.99	6.88%	-0.52%
GOOG	1.7T	289.5B	-1.19%	40.58%	27.62	5.81	4.10%	-15.36%
AMZN	1.3T	538.0B	-6.27%	14.57%	98.4	2.39	10.73%	12.62%
MID-CAP
JBLU	1.5B	9.9B	-21.75%	-30.02%	55.62	0.15	24.14%	106.11%
NYMT	743.7M	246.5M	-12.96%	-3.78%	-4.68	3.02	6.65%	-174.04%
SMALL-CAP
PLAY	1.5B	2.2B	-7.08%	18.88%	10.95	0.7	38.20%	-10.10%
TLRY	1.5B	627.1M	-7.75%	-17.45%	-1.01	2.35	-0.20%	-204.67%
NKLA	1.1B	56.2M	19.49%	-59.94%	-1.33	19.99	40.31%	-12.26%
MFA	894.8M	543.3M	-14.90%	19.67%	-616.27	1.65	31.74%	78.13%
BYND	559.6M	356.8M	-23.26%	-34.79%	-1.99	1.57	-23.03%	15.53%
GPRO	474.5M	1.0B	-17.03%	-38.74%	-17.95	0.46	-11.34%	-107.10%
CGC	376.1M	453.3M	34.00%	-73.00%	-0.31	0.83	-16.04%	55.90%
INO	100.2M	13.7M	-13.82%	-77.44%	-0.6	7.34	413.65%	52.51%

Inari Medical News

Returns for NARI

Cumulative Returns on NARI

0.9%

3-Year Cumulative Returns

Risks for NARI

What is the probability of a big loss on NARI?

89.8%

Probability that Inari Medical stock will be more than 20% underwater in next one year

70.6%

Probability that Inari Medical stock will be more than 30% underwater in next one year.

30.5%

Probability that Inari Medical stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NARI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Inari Medical was unfortunately bought at previous high price.

Drawdowns

Financials for Inari Medical

Income Statement (Last 12 Months)

Income Statement (Last 12 Months)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2018Q4
Revenue	6.4%	439,147,000	412,886,000	383,471,000	358,918,000	335,630,000	306,339,000	276,984,000	242,377,000	208,176,000	170,115,000	139,670,000	110,947,000	86,457,000	71,137,000	51,129,000	48,594,000	40,288,000	6,829,000
Gross Profit	6.2%	387,370,000	364,606,000	338,965,000	319,260,000	299,996,000	276,238,000	252,227,000	222,214,000	191,825,000	155,091,000	126,564,000	99,387,000	76,615,000	63,451,000	45,218,000	42,912,000	34,964,000	5,548,000
Operating Expenses	3.8%	409,907,000	394,961,000	367,064,000	339,722,000	313,387,000	276,189,000	241,383,000	206,120,000	165,814,000	133,795,000	108,145,000	86,794,000	70,319,000	57,194,000	44,417,000	42,410,000	37,532,000	14,688,000
S&GA Expenses	3.9%	327,241,000	314,811,000	292,843,000	267,187,000	247,458,000	217,199,000	190,365,000	167,292,000	134,268,000	110,251,000	89,746,000	72,222,000	59,242,000	48,165,000	37,197,000	35,806,000	31,212,000	10,698,000
R&D Expenses	3.1%	82,666,000	80,150,000	74,221,000	72,535,000	65,929,000	58,990,000	51,018,000	38,828,000	31,546,000	23,544,000	18,399,000	14,572,000	11,077,000	9,029,000	7,220,000	6,604,000	6,320,000	3,990,000
EBITDA	100.0%	-	-19,031,000	-21,218,000	-15,045,000	-8,826,000	3,672,000	14,014,000	18,846,000	27,801,000	18,206,000	14,924,000	8,457,000	2,302,000	4,907,000	-272,000	-288,000	-2,944,000	-
EBITDA Margin	100.0%	-	-0.05	-0.06	-0.04	-0.03	0.01	0.05	0.08	0.13	0.11	0.11	0.08	0.03	0.07	-0.01	-0.01	-0.07	-
Interest Expenses	-11.1%	232,000	261,000	294,000	295,000	294,000	295,000	295,000	295,000	473,000	862,000	1,135,000	1,298,000	1,273,000	1,039,000	920,000	910,000	916,000	887,000
Earnings Before Taxes	49.3%	-12,291,000	-24,250,000	-26,185,000	-19,696,000	-13,126,000	-111,000	10,685,000	15,989,000	25,228,000	17,344,000	13,789,000	9,072,000	616,000	16,448,000	-1,192,000	-	-	-
EBT Margin	100.0%	-	-0.06	-0.07	-0.05	-0.04	0.00	0.04	0.07	0.12	0.10	0.10	0.06	0.01	0.05	-0.02	-0.02	-0.10	-
Net Income	43.3%	-16,084,000	-28,356,000	-29,267,000	-22,362,000	-15,013,000	-758,000	9,840,000	15,718,000	25,018,000	17,146,000	13,789,000	7,159,000	1,029,000	3,868,000	-1,192,000	-2,062,666	-3,826,000	-10,153,000
Net Income Margin	100.0%	-	-0.07	-0.08	-0.06	-0.04	0.00	0.04	0.06	0.12	0.10	0.10	0.06	0.01	0.05	-0.02	-0.04	-0.09	-
Free Cashflow	100.0%	-	-15,055,000	-23,923,000	-21,111,000	-16,066,000	-7,505,000	11,841,000	-4,456,000	9,557,000	5,241,000	-3,548,000	-1,448,000	-6,629,000	-6,258,666	-8,080,000	-5,992,000	-9,348,000	-

Balance Sheet
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet														(In Millions)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2019Q4
Assets	3.6%	525	507	504	488	484	484	312	292	254	235	214	206	224	45.00
Current Assets	4.5%	445	426	423	411	411	413	245	228	228	221	206	199	220	39.00
Cash Equivalents	2.3%	58.00	57.00	60.00	84.00	80.00	187	93.00	81.00	91.00	103	115	24.00	195	24.00
Inventory	6.8%	39.00	36.00	33.00	30.00	27.00	24.00	21.00	19.00	18.00	14.00	11.00	7.00	6.00	4.00
Net PPE	-0.9%	21.00	21.00	22.00	21.00	20.00	18.00	16.00	15.00	11.00	7.00	7.00	5.00	4.00	3.00
Liabilities	11.9%	89.00	80.00	87.00	73.00	70.00	65.00	72.00	58.00	32.00	21.00	14.00	14.00	40.00	30.00
Current Liabilities	20.5%	58.00	48.00	56.00	42.00	41.00	36.00	43.00	30.00	32.00	21.00	14.00	14.00	11.00	9.00
Shareholder's Equity	2.1%	436	427	417	415	414	419	239	234	222	214	200	191	184	-
Retained Earnings	4.2%	-46.98	-49.07	-46.85	-41.05	-30.90	-20.71	-17.58	-18.69	-15.89	-19.95	-27.42	-34.41	-40.90	-41.21
Additional Paid-In Capital	1.7%	484	476	463	457	446	440	257	253	238	234	228	226	225	2.00
Shares Outstanding	0.3%	57.00	57.00	54.00	54.00	53.00	51.00	50.00	50.00	50.00	49.00	49.00	48.00	24.00	7.00

Cashflow (Last 12 Months)
(In Millions)

Cashflow (Last 12 Months)																		(In Millions)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2018Q4
Cashflow From Operations	186.2%	6.00	-6.88	-13.97	-10.22	-2.74	8.00	25.00	9.00	20.00	11.00	2.00	3.00	-2.97	-2.45	-4.94	-1.34	-7.55	-10.89
Share Based Compensation	9.8%	36.00	32.00	29.00	26.00	31.00	28.00	25.00	23.00	11.00	7.00	4.00	2.00	1.00	1.00	1.00	1.00	0.00	0.00
Cashflow From Investing	76.2%	-29.97	-125	-195	-164	-185	-102	-51.02	-100	-94.96	-77.34	-55.44	-4.16	-3.66	-3.81	-3.14	-4.65	-1.80	-0.75
Cashflow From Financing	-24.7%	2.00	3.00	177	178	177	178	4.00	5.00	-28.60	136	144	154	185	27.00	10.00	1.00	0.00	27.00

NARI Income Statement

2023-06-30

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue	$ 119,005	$ 92,744	$ 235,172	$ 179,496
Cost of goods sold	13,844	10,347	27,585	20,314
Gross profit	105,161	82,397	207,587	159,182
Operating expenses
Research and development	21,085	18,569	43,149	34,704
Selling, general and administrative	85,586	73,156	171,286	136,888
Total operating expenses	106,671	91,725	214,435	171,592
Loss from operations	(1,510)	(9,328)	(6,848)	(12,410)
Other income (expense)
Interest income	4,552	214	8,697	264
Interest expense	(44)	(73)	(84)	(146)
Other income	26	252	65	228
Total other income	4,534	393	8,678	346
Income (loss) before income taxes	3,024	(8,935)	1,830	(12,064)
Provision for income taxes	939	1,252	1,963	1,252
Net income (loss)	2,085	(10,187)	(133)	(13,316)
Other comprehensive income (loss)
Foreign currency translation adjustments	(79)	(291)	(70)	(408)
Unrealized loss on available-for-sale debt securities	(1,095)	(125)	(1,960)	(373)
Total other comprehensive loss	(1,174)	(416)	(2,030)	(781)
Comprehensive income (loss)	$ 911	$ (10,603)	$ (2,163)	$ (14,097)
Net income (loss) per share
Basic (in dollars per share)	$ 0.04	$ (0.19)	$ (0.00)	$ (0.26)
Diluted (in dollars per share)	$ 0.04	$ (0.19)	$ (0.00)	$ (0.26)
Weighted average common shares used to compute net income (loss) per share
Basic (in shares)	57,207,902	53,183,767	55,988,736	52,075,399
Diluted (in shares)	58,496,350	53,183,767	55,988,736	52,075,399

NARI Balance Sheet

2023-06-30

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 57,837	$ 60,222
Short-term investments in debt securities	279,696	266,179
Accounts receivable, net	63,128	58,611
Inventories, net	38,984	32,581
Prepaid expenses and other current assets	4,972	5,312
Total current assets	444,617	422,905
Property and equipment, net	21,063	21,655
Operating lease right-of-use assets	49,857	50,703
Deposits and other assets	9,431	8,889
Total assets	524,968	504,152
Current liabilities
Accounts payable	7,240	7,659
Payroll-related accruals	38,290	38,955
Accrued expenses and other current liabilities	11,125	8,249
Operating lease liabilities, current portion	1,583	1,311
Total current liabilities	58,238	56,174
Operating lease liabilities, noncurrent portion	31,085	30,976
Total liabilities	89,323	87,150
Commitments and contingencies (Note 7)
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2023 and December 31, 2022	0	0
Common stock, $0.001 par value, 300,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 57,266,455 and 54,021,656 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	57	54
Additional paid in capital	483,752	462,949
Accumulated other comprehensive (loss) income	(1,181)	849
Accumulated deficit	(46,983)	(46,850)
Total stockholders' equity	435,645	417,002
Total liabilities and stockholders' equity	$ 524,968	$ 504,152

Inari Medical, Inc. Stock Research

Market Summary

NARI Alerts

NARI Stock Price

NARI RSI Chart

NARI Valuation

NARI Price/Sales (Trailing)

NARI Profitability

NARI Fundamentals

NARI Revenue

NARI Earnings

Price Action

52 Week Range

NARI Financial Health

NARI Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for NARI

Which funds bought or sold NARI recently?

Latest Funds Activity

NARI Alerts

Schedule 13G FIlings of Inari Medical

Recent SEC filings of Inari Medical

Peers (Alternatives to Inari Medical)

Inari Medical News

Returns for NARI

Cumulative Returns on NARI

Risks for NARI

What is the probability of a big loss on NARI?

How does NARI drawdown profile look like?

Financials for Inari Medical

Income Statement (Last 12 Months)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)

NARI Income Statement

NARI Balance Sheet

About Inari Medical

Market Summary

NARI Alerts

NARI Stock Price

NARI RSI Chart

NARI Valuation

NARI Price/Sales (Trailing)

NARI Profitability

NARI Fundamentals

NARI Revenue

NARI Earnings

Price Action

52 Week Range

NARI Financial Health

NARI Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for NARI

Which funds bought or sold NARI recently?

Latest Funds Activity

NARI Alerts

Schedule 13G FIlings of Inari Medical

Recent SEC filings of Inari Medical

Peers (Alternatives to Inari Medical)

Inari Medical News

Returns for NARI

Cumulative Returns on NARI

Risks for NARI

What is the probability of a big loss on NARI?

How does NARI drawdown profile look like?

Financials for Inari Medical

Income Statement (Last 12 Months)

Balance Sheet.css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Cashflow (Last 12 Months)(In Millions)

NARI Income Statement

NARI Balance Sheet

About Inari Medical

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)